What are the contraindications for azelastine ophthalmic solution (eye drops)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Contraindications for Azelastine Eye Drops

The only contraindication to azelastine ophthalmic solution is known or suspected hypersensitivity to azelastine or any component of the formulation 1.

Key Clinical Points

This is a remarkably safe medication with minimal contraindications. The FDA drug label explicitly states that hypersensitivity reactions are the sole contraindication 1. This makes azelastine eye drops suitable for a broad patient population with allergic conjunctivitis.

What This Means in Practice:

  • No age restrictions: Safe for both adults and children
  • No systemic disease contraindications: Unlike systemic antihistamines or other ophthalmic agents, there are no cardiovascular, respiratory, or metabolic contraindications
  • No drug interactions listed as contraindications: The selective H1-antagonist mechanism and low systemic absorption (plasma concentrations 0.02-0.25 ng/mL) minimize interaction risks 1

Components to Consider for Hypersensitivity:

The formulation contains 1:

  • Active ingredient: Azelastine hydrochloride 0.05%
  • Preservative: Benzalkonium chloride 0.25 mg/mL
  • Inactive ingredients: Disodium edetate, hypromellose, sorbitol, sodium hydroxide

Common pitfall: Patients may confuse local tolerability issues (transient burning, bitter taste) with true hypersensitivity. Application site reactions occur in up to 37% of patients but are typically mild, transient, and do not constitute contraindications 2. These reactions tend to diminish with continued use 3.

Safety Profile:

Clinical trials demonstrate excellent tolerability with premature discontinuation due to adverse effects in less than 2% of patients 4. The most frequent side effects are:

  • Transient application site irritation
  • Bitter or unpleasant taste (due to nasolacrimal drainage)
  • Mild burning sensation

These are not contraindications but rather expected tolerability issues that should be discussed during counseling.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.